-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNIC INC - TOP-LINE DATA FOR PHASE 3 ENSURE TRIALS EXPECTED END OF 2026

Reuters·06/05/2025 10:30:03

Please log in to view news